Read the most recent news on the Vybion's Huntington's Therapy from the Huntington's Disease News.
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease, Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic Phase 3 clinical trial…
Gene Silencing Therapies
Huntington's Disease News reports on a new treatment known as Gene Silencing Therapies. Read more by Victoria Tan here.